Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
Apr 1, 2022 • 3min
Association Between Cancer and Guillain-Barré Syndrome
Dr. Rae Bacharach discusses the Neurology Today article, "Large Population-Based Study Finds an Association Between Cancer and Guillain-Barré Syndrome". Show references: https://journals.lww.com/neurotodayonline/Fulltext/2022/03170/Large_Population_Based_Study_Finds_an_Association.8.aspx
Mar 31, 2022 • 2min
Spinal Muscular Atrophy
Dr. Charlotte Sumner discusses spinal muscular atrophy, highlighting the historic milestone reached with three medications receiving FDA approval for the treatment of SMA.
Mar 30, 2022 • 4min
Neuro-respiratory Criteria for Death Determination
Drs. Ariane Lewis and David Magnus discuss the need to update the Uniform Declaration of Death Act (UDDA), aligning the legal criteria with the medical standards used to determine death by neurological criteria. Show references: https://n.neurology.org/content/early/2022/01/25/WNL.0000000000200024
Mar 29, 2022 • 2min
LGI1 Antibody Encephalitis
Dr. Keng Lam discusses LGI1 antibody encephalitis.
Mar 28, 2022 • 2min
Careers in Neurology: Transcranial Stimulation
Dr. Katrina Ignacio discusses the emerging subspecialty of Transcranial Stimulation.
Mar 25, 2022 • 2min
Neurology of Pregnancy
Dr. Mary Angela O'Neal discusses the February Continuum issue on the Neurology of Pregnancy.
Mar 24, 2022 • 2min
Cognitive Outcomes in mTBI
Dr. Raquel Gardner discusses the development of a clinically-relevant definition of poor cognitive outcome one year after mild traumatic brain injury (mTBI) and whether outcomes can be predicted by baseline clinical variables. Show references: https://pubmed.ncbi.nlm.nih.gov/35173018/
Mar 23, 2022 • 3min
ARIA Associated with Aducanumab
Dr. Lon Schneider discusses the development of ARIA in Phase 3 EMERGE and ENGAGE trials that led to the FDA's accelerated approval of aducanumab for the treatment of MCI Alzheimer's disease. Show references: https://www.alzforum.org/news/research-news/aduhelm-phase-3-data-aria-common-sometimes-serious
Mar 22, 2022 • 2min
Epilepsy & Pregnancy - Part 2
In part 2 of a 2 part series, Yi Li, MD, Ph.D., discusses her article, "Epilepsy and Pregnancy" from the February Neurology of Pregnancy Continuum issue. This article and the accompanying Continuum Audio interview are available to all at continpub.com/EpilepsyPreg until May 1, 2022.
Mar 21, 2022 • 2min
Epilepsy & Pregnancy - Part 1
In part 1 of a 2 part series, Yi Li, MD, Ph.D., discusses her article, "Epilepsy and Pregnancy" from the February Neurology of Pregnancy Continuum issue. This article and the accompanying Continuum Audio interview are available to all at continpub.com/EpilepsyPreg until May 1, 2022.
